National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D07XC04	AZONIT - D	G	Diflucortolone valerate - 1mg/g, Isoconazole nitrate - 10mg/g		Cream	225,766 L.L
D10AD01	A-RET	G	Tretinoin - 0.05%	0.05%	Cream	335,961 L.L
D10AD01	AVOTIN-A	G	Tretinoin - 0.05%	0.05%	Cream	440,780 L.L
C05A	ANTROLIN	B	Nifedipine - 0.3%, Lidocaine - 1.5%		Cream	1,333,092 L.L
D10AD06	AKLIEF	B	Trifarotene - 50mcg/g	50mcg/g	Cream	4,359,425 L.L
M02AA	AIRTAL DIFUCREM 1.5%	B	Aceclofenac - 1.5g/100g	1.5%	Cream	536,193 L.L
D11AX11	AVOQUIN	G	Hydroquinone - 4%	4%	Cream	916,501 L.L
D06AX01	ACIDE FUSIDIQUE BGR	G	Fusidic acid - 2%	2%	Cream	202,920 L.L
D06BB10	ALDARA	B	Imiquimod - 5%	5%	Cream	6,301,277 L.L
D06BB53	ACTI-VIR H	G	Aciclovir - 5%, Hydrocortisone acetate - 1%		Cream	833,182 L.L
S01AE07	AROX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	423,310 L.L
S01EE01	API-LOPROST	G	Latanoprost - 0.005%	0.005%	Drops	447,500 L.L
S03AA07	API-CIPROCIN	G	Ciprofloxacine (HCl) - 3mg/ml	3mg/ml	Drops	530,818 L.L
S01AA26	AZYTER	G	Azithromycin (dihydrate) - 15mg/g	15mg/g	Drops solution	412,560 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	1,001,163 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	1,001,163 L.L
S01EA05	ALPHANOVA	G	Brimonidine tartrate - 0.15%	0.15%	Drops solution	599,354 L.L
S01GA04	ALERJON	G	Oxymetazoline HCl -		Drops solution	528,130 L.L
S01GX07	ALLERGODIL	B	Azelastine HCl - 0.5mg/ml	0.5mg/ml	Drops solution	709,549 L.L
S01HA02	ANESTOCIL	B	Oxybuprocaine HCl (Benoxinate HCl) - 0.4%	0.4%	Drops solution	442,124 L.L
S01CA01	API-TOBRASON	G	Dexamethasone - 1mg/ml, Tobramycin - 3mg/ml		Drops suspension	294,302 L.L
S01EC04	AZOPT	B	Brinzolamide - 10mg/ml	10mg/ml	Drops suspension	804,962 L.L
A07EC02	ASACOL	B	Mesalazine - 1g/100ml	1g/100ml	Enema	2,748,158 L.L
G04BE08	AMOS	G	Tadalafil - 20mg	20mg	Film, orodispersible	2,175,745 L.L
G04BE08	AMOS	G	Tadalafil - 10mg	10mg	Film, orodispersible	1,662,781 L.L
G04BE08	AMOS	G	Tadalafil - 5mg	5mg	Film, orodispersible	2,743,998 L.L
M02AA10	ACHONID GEL	G	Ketoprofen - 2.5%	2.5%	Gel	179,179 L.L
D11AX18	ALMIRAL	G	Diclofenac sodium - 1% w/w	1% w/w	Gel	396,434 L.L
R03DC03	AIRFAST PEDIATRICS	G	Montelukast (sodium) - 4mg	4mg	Granules for solution	880,217 L.L
R03AL01	ATROVENT COMP. HFA	B	Fenoterol Hydrobromide - 20mcg/actuation, Ipratropium bromide - 50mcg/actuation		Inhalation aerosol metered dose	544,256 L.L

National Cancer Registry (NCR)